Riskpilot← Back to searchSign inGet full accessDALE APOTEK AS
ASActiveOrg 916668244Skulegata 2, 5722 DalekvamRetail sale of pharmaceutical products · NACE 4773Est. 20160 employees
Revenue 2022
NOK 15,1M
+2% vs 2021
EBITDA margin
1.7%
-23% vs 2021
Equity ratio
13.9%
Financial strength
Net profit 2022
NOK 138K
-22% vs 2021
| Revenue | NOK 15,1M | +2% |
| EBITDA | NOK 259K | -23% |
| Net profit | NOK 138K | -22% |
| Total assets | NOK 2,2M | -56% |
| Equity | NOK 310K | +80% |
| Employees | 0 | — |
Legal name
DALE APOTEK AS
Org number
916668244
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
4. februar 2016
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eierskap og drift av apotek, handel med apotekvarer og relaterte produkter, aktuelle konsulent og rådgivningstjenester.
Address
Skulegata 2, 5722 Dalekvam
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 13 303 | 12 809 | 14 632 | 14 825 | 15 106 |
| Staff expenses | −2 468 | −2 457 | −2 516 | −2 620 | −2 598 |
| EBITDA | 215 | −172 | 628 | 336 | 259 |
| Depreciation & amort. | −126 | −142 | −142 | −111 | −83 |
| EBIT | 89 | −314 | 487 | 226 | 176 |
| Net financials | −6 | −40 | 0 | 0 | 1 |
| Profit before tax | 83 | −354 | 487 | 226 | 177 |
| Tax | −153 | −19 | 50 | 50 | 39 |
| Net profit | 236 | −334 | 437 | 176 | 138 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 3 450 | 3 918 | 3 548 | 5 035 | 2 227 |
| Equity | 153 | −181 | 204 | 172 | 310 |
| Long-term debt | 709 | 1 468 | 1 425 | 1 231 | 21 |
| Short-term debt | 2 588 | 2 632 | 1 919 | 3 632 | 1 895 |
| Total debt | 3 297 | 4 100 | 3 344 | 4 863 | 1 917 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20182022
Equity ratio
13.9%
This company
38.2%
Market median
-64% vs market
20182022
Return on equity
44.5%
This company
18.4%
Market median
+142% vs market
20182022
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20182022
Asset turnover
6.78×
This company
1.12×
Market median
+505% vs market
20182022
Debt / equity
6.18×
This company
0.62×
Market median
-897% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JE Deputy Member | Deputy Member | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2016 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
DALE APOTEK AS Board members of DALE APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erik Helgemo | Deputy Member | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Håvard Røkke | Chairman | 0 companies |